Proxidol

Quick links to important sections

Medically reviewed

Laura Arias

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Proxidol

Proxidol is a synthetic medicine used to provide relief from pain, inflammation, and fever, belonging to the class of Nonsteroidal Anti-inflammatory Drugs (NSAIDs). Its identity is defined by its single active component, Naproxen Sodium, and it is formulated for oral administration.


Property Description
Active Ingredient Naproxen Sodium
Form Tablet, Caplet, Capsule, Oral suspension
Pharmacological Class Nonsteroidal Anti-inflammatory Drug (NSAID)
General Purpose Analgesic, Anti-inflammatory, and Antipyretic relief
Origin Synthetic compound (Propionic acid derivative)

What Type of Medicine is Proxidol? (Identity and Classification)

Proxidol is a commercial brand utilizing Naproxen Sodium, a compound that is chemically classified as a Propionic acid derivative and functionally as an NSAID. This classification establishes the medicine's fundamental scope: its purpose is to deliver analgesic (pain-relieving), anti-inflammatory (swelling-reducing), and antipyretic (fever-reducing) effects simultaneously.

Naproxen is used as a medicine to lessen pain and inflammation. Its origin is entirely synthetic, created through established chemical processes rather than being directly extracted from natural sources.

Compositional Forms and General Purpose (Form and Benefit)

The active component, Naproxen Sodium, is combined with pharmaceutical excipients to create various oral forms, allowing for oral administration. While other formulations exist, Proxidol is typically positioned as an over-the-counter (OTC) medicine in lower doses for adult use. Its general purpose is to mitigate discomfort often associated with musculoskeletal strain or minor injuries. Utilizing the highly soluble sodium salt formulation is a key differentiating element for promoting faster dissolution and absorption into the systemic circulation compared to the standard Naproxen base.

How Proxidol Differs From Other Analgesics (Conceptual Distinction)

Proxidol differs from other types of pain relievers, such as opioids, because it functions by inhibiting the synthesis of prostaglandins primarily at the periphery, rather than modulating nerve signaling in the central nervous system. Its action as a Cyclooxygenase inhibitor means its benefits are comprehensive, addressing both the transmission of pain signals and the underlying biological cause of localized inflammation. This peripheral, non-opioid mechanism defines its suitability for addressing general inflammatory pain and fever.

Regulatory References

  1. MedlinePlus Drug Information on Naproxen

What side effects are possible with Proxidol?

Possible Side Effects and Safety Information

The safety profile of Proxidol is structured around potential adverse reactions and specific limitations, as detailed in regulatory documents. It is important for patients and prescribers to be aware of all documented risks.

Common and Serious Adverse Reactions

The most Very Common adverse reactions reported include headache and dyspepsia (indigestion). Common side effects typically involve the gastrointestinal and nervous systems, such as dizziness, nausea, abdominal pain, and skin rash.

Serious and Clinically Significant Adverse Reactions are explicitly highlighted in the official prescribing information, including the potential for severe, life-threatening events. These encompass anaphylactic reactions, agranulocytosis (a severe drop in white blood cell count), and instances of severe hepatic impairment (liver failure). The label also carries a Black Box Warning from the US Food and Drug Administration (FDA) regarding the risk of serious cardiovascular thrombotic events (e.g., heart attack, stroke) and serious gastrointestinal bleeding and ulceration.

Safety Restrictions and Monitoring

Proxidol is contraindicated in patients with a known hypersensitivity to the drug or its components, as well as in the immediate setting of coronary artery bypass graft (CABG) surgery. A specific restriction mandates caution and potential dose adjustment for patients with pre-existing gastrointestinal bleeding risks or severe renal impairment (creatinine clearance < 30 mL/min). The risk of serious gastrointestinal hemorrhage is noted to be dose-dependent.

Regulatory guidance emphasizes the need for hepatic function monitoring during the first six months of therapy due to the risk of hepatotoxicity. Patients who exhibit signs of liver injury, such as jaundice or significantly elevated liver enzymes, must discontinue the product immediately. The maximum daily dose should not be exceeded to mitigate the increased safety risks associated with higher exposure.

Overdose and Emergency Response

Overdose and When to Seek Help

Regulatory documentation defines the overdose profile for Proxidol (Naproxen Sodium) based on documented clinical manifestations and mandatory emergency actions.


Documented Overdose Presentations

Symptoms following an overdose typically involve the Gastrointestinal (GI) and Central Nervous System (CNS) systems. Manifestations may include nausea, vomiting, heartburn, stomach pain, drowsiness, dizziness, tinnitus, and confusion. Severe overdose carries the risk of life-threatening outcomes, including severe gastrointestinal bleeding, ulceration, and acute kidney failure, which can lead to metabolic complications like acidosis.


Required Emergency Actions

No specific antidote is known for Naproxen Sodium overdose, according to regulatory information. Therefore, management is restricted to symptomatic and supportive treatment.

  • Mandatory Action: Regulatory authorities explicitly state that any suspected overdose requires the user to seek immediate medical attention.
  • Emergency Contact: Individuals should contact emergency services or a Poison Help Line right away, as stated in official guidance.

Population Considerations

Older adults and patients with underlying renal or hepatic impairment are recognized as being at a heightened risk for experiencing more severe adverse outcomes following an overdose event.

Therapeutic Uses of Proxidol

What Proxidol Treats: Main Uses and Benefits

Proxidol (Naproxen Sodium) is applied across domains where additional symptomatic support is needed, primarily focusing on managing pain, inflammation, and fever. Its use is relevant when supportive symptom management is appropriate for symptoms that may interfere with daily functioning. The medication is commonly used to help with symptomatic relief for conditions involving inflammatory or irritative processes.

These include long-term issues like rheumatoid arthritis, osteoarthritis, and ankylosing spondylitis, as well as acute episodes such as gouty arthritis flare-ups, migraines, sprains, strains, and recurrent primary dysmenorrhea (menstrual cramps). It helps address symptom clusters that may become intense or disruptive, offering symptomatic relief that supports patients during difficult episodes.

Therapeutic Focus: Symptom Relief

Proxidol is relevant for easing symptoms related to physical discomfort and may help patients cope more steadily with symptom fluctuations, contributing to improved comfort during periods of heightened symptoms.

Regulatory References

  1. NIH DailyMed Drug Label for Naproxen Sodium

Eligibility and Restrictions for Use

Who Can and Cannot Use Proxidol?

Proxidol (Naproxen Sodium) eligibility is strictly defined by government regulatory documents, focusing on absolute contraindications and population restrictions.

Contraindicated Populations

Use is prohibited for patients with a known hypersensitivity to naproxen or a history of allergic reactions (e.g., asthma, urticaria) after taking aspirin or other NSAIDs. The medicine is also contraindicated in the setting of Coronary Artery Bypass Graft (CABG) surgery and for pregnant women at 30 weeks gestation or later (the third trimester). Eligibility is further restricted for individuals with active peptic ulceration, active GI bleeding, or severe heart, renal, or hepatic failure.

Age and Restricted Use

Proxidol is approved for adults and for children 12 years and older (for general non-prescription use). Safety and efficacy have not been established for children younger than 2 years of age. Use in the elderly (over 60) requires caution, recommending the lowest effective dose for the shortest duration due to increased risk of serious adverse effects. The medicine is not recommended for lactating/breastfeeding mothers or during pregnancy between 20 to 30 weeks gestation without careful consideration.

What should I know about interactions with other medicines?

Interactions with other medicines and products

The interaction profile of Proxidol (Naproxen Sodium) is defined by its potential for additive pharmacodynamic effects and the alteration of plasma concentrations for both itself and co-administered medicines. All interaction information is based strictly on official regulatory documents.

Interaction Classification Interacting Agents and Official Outcome
Contraindicated Combinations Co-administration with other NSAIDs (including aspirin at analgesic doses) and Ketorolac is formally prohibited due to the additive risk of severe gastrointestinal and bleeding events.
Exposure Alteration (PK) Concurrent use with Methotrexate is documented to reduce its renal clearance, leading to increased plasma concentrations and potential toxicity. Probenecid has a similar effect, increasing the plasma concentration and prolonging the half-life of Naproxen. Naproxen is also a weak CYP2C9 inhibitor.
Additive Pharmacodynamic Risk Co-administration with Anticoagulants (e.g., Warfarin), Corticosteroids, and SSRIs increases the documented risk of gastrointestinal bleeding. Additionally, use with ACE Inhibitors, ARBs, or Diuretics may diminish their expected therapeutic effect and increase the documented risk of renal function deterioration.
Food and Substance Constraints Alcohol may increase the risk of gastrointestinal bleeding. Food intake can affect the rate, but not the overall extent, of Naproxen absorption.

These constraints structure the regulatory profile around avoiding additive toxicity and managing the reduced clearance of specific co-administered drugs. Interactions that affect renal function may be more pronounced in the elderly or those with existing impairment, as noted in official labeling.

Mechanism of Action

Proxidol's action is defined by its ability to modulate the body's eicosanoid system, resulting in predictable physiological changes. The Sodium salt formulation enhances aqueous solubility, leading to rapid attainment of effective inhibitory concentrations.


Modulation of Prostaglandin Synthesis (Anti-Inflammatory and Analgesic Mechanism)

This domain covers the reversible inhibition of the Cyclooxygenase ( COX) enzymes ( COX-1 and COX-2), the primary biological targets. By blocking these enzymes, the drug prevents the conversion of arachidonic acid into prostanoid mediators , which are responsible for lowering the threshold of peripheral nociceptors (pain sensors). The resulting physiological change is the modulation of nociceptor threshold and attenuation of localized prostanoid-mediated vascular effects.


Central Regulation of the Thermoregulatory Set-Point (Antipyretic Mechanism)

This domain involves a specific action within the Central Nervous System (CNS), localized to the Hypothalamus. The mechanism suppresses the production of Prostaglandin E2 ( PGE2) in this region, which is the key mediator that elevates the body's internal temperature set-point. The physiological consequence of this targeted action is the re-establishment of the normal thermal set-point.

Dosage and Administration Information

How to Use Proxidol: Official Administration Guidelines

Proxidol (Naproxen Sodium) administration is based on established parameters outlining dosing and intake conditions. This medicine is for oral administration only, available across several forms, including standard and delayed-release tablets, capsules, and an oral suspension.


Official Usage Patterns

Instruction Entity Regulatory Standard
Dosing Range Typically 500 mg to 1,000 mg total daily dose for chronic use, with temporary higher doses up to 1,500 mg available.
Frequency Most often administered twice daily for standard release forms or once daily for extended-release formulations. Acute use may involve taking a dose every 6 to 12 hours.
Food Relationship Recommended to be taken with food, milk, or an antacid to minimize local irritation.

Procedural and Population Constraints

The administration protocol includes the principle of using the lowest effective dose for the shortest duration necessary. Specific formulations, such as delayed-release or extended-release tablets, must be swallowed whole and not crushed, broken, or chewed to preserve the integrity of their drug release mechanism.

For older adults, guidelines include initiating treatment at the lowest end of the approved dosing range. Similarly, patients with existing renal or hepatic impairment typically require a reduction in the standard dose and close professional oversight to manage reduced clearance.

Recent Clinical Evidence

Research Evidence / Overview of Studies for Proxidol

The clinical research evaluating Proxidol (Naproxen Sodium) focuses on how this medicine was studied in the context of symptoms across several conditions. The context for this research is provided by official reviews and extensive meta-analyses of Randomized Controlled Trials (RCTs). These studies typically compare the medicine against a comparison treatment, such as a placebo or another active drug, under controlled conditions.


Evidence for Use in Chronic Inflammatory Conditions (Osteoarthritis and Rheumatoid Arthritis)

Clinical development for conditions characterized by fluctuating or episodic manifestations, such as Osteoarthritis (OA) and Rheumatoid Arthritis (RA), was studied for symptom patterns in adult patients. Researchers examined outcomes related to physical discomfort, functional imbalance, and overall disease activity scores. The findings describe patterns observed in the studies over short-term periods, typically tracking patients for several weeks to several months. Follow-up durations were limited in many core studies, and long-term effects are not fully established by primary efficacy trials. Some comparative studies against other active treatments were inadequately powered to draw definitive conclusions.


Evidence for Use in Acute Pain Relief (Migraine, Postoperative Pain, and Dysmenorrhea)

Proxidol was studied for acute and episodic conditions, including migraine and various sources of postoperative pain. This research utilized single-dose and multiple-dose RCTs, which explored short-term symptom patterns using outcomes related to episodic or acute changes in physical discomfort. For instance, studies measured metrics like the time until patients reported a change in pain and the documentation of rescue medication usage. The evidence base is limited in that it primarily measures short-term acute symptoms; long-term usage data is not applicable to these indications. For acute migraine, comparative evidence is lacking in large-scale head-to-head trials against the full range of alternative acute migraine treatments.


Research Gaps and Areas of Scientific Uncertainty

The body of evidence highlights areas where research is ongoing or where certainty remains low. Follow-up durations were limited in many core efficacy trials, meaning that long-term effects are not fully established. Additionally, subgroup findings are uncertain in some areas due to modest sample sizes, and research does not determine whether an individual will respond similarly to the group patterns observed in the studies.

Key Studies & References

  1. Naproxen Sodium Tablet, Film Coated (Official Drug Label)
  2. Naproxen: MedlinePlus Drug Information

Frequently Asked Questions (FAQ)

Common questions about Proxidol (FAQ)


Q: How is Proxidol different from other medications that treat similar issues?

A: Official documents describe Proxidol's active ingredient as a Nonsteroidal Anti-inflammatory Drug (NSAID) that is chemically classified as a Propionic acid derivative. This classification means its mechanism of action involves inhibiting enzymes that cause inflammation and pain, which distinguishes it from non-NSAID pain relievers.


Q: Can Proxidol be taken long-term?

A: Regulatory guidance emphasizes the principle of using the lowest effective dose for the shortest possible duration. This official protocol is in place because chronic, long-term use is associated with documented risks, including potential for serious cardiovascular and gastrointestinal events.


Q: Does Proxidol interact with common over-the-counter cold medicines?

A: Official safety documents document a contraindication for co-administration with other Nonsteroidal Anti-inflammatory Drugs (NSAIDs). This is a crucial warning, as many over-the-counter cold and flu preparations often contain an NSAID, and combining these can increase the risk of severe adverse events.


Q: Can taking Proxidol affect my ability to drive?

A: Regulatory warnings state that common side effects, such as dizziness and drowsiness, may affect a person's ability to operate vehicles or machinery safely. Official information notes that if these central nervous system effects occur, activities requiring mental alertness should be avoided.


Q: How quickly does Proxidol typically start to work?

A: Proxidol, which uses the highly soluble sodium salt formulation, promotes rapid absorption into the body. Official pharmacokinetic studies document that the time to reach maximum concentration of the active ingredient is typically between 1 to 2 hours after administration.


Q: Is there a generic version of Proxidol available?

A: Proxidol is the brand name for the active compound, Naproxen Sodium. Official regulatory bodies list Naproxen Sodium as a generic equivalent, which means it is available in generic form.


Q: What is the expected duration of treatment with Proxidol?

A: The precise duration of treatment is an individualized determination made by a healthcare professional based on the condition being treated. However, official regulatory protocol consistently mandates using the shortest effective duration possible to manage symptoms.


Q: Are there any long-term effects of Proxidol that I should know about?

A: Official safety documents detail serious risks associated with prolonged use. This includes a Black Box Warning from the FDA regarding an increased risk of serious cardiovascular thrombotic events (such as heart attack or stroke) and severe gastrointestinal bleeding and ulceration.


Q: Can Proxidol affect blood pressure?

A: Official regulatory documents contain warnings that Proxidol may lead to the onset of new hypertension or could potentially worsen existing high blood pressure. Additionally, it has been noted to reduce the expected effect of certain blood pressure-lowering medications.


Q: Are there specific food types that interact with Proxidol?

A: Official information on the medicine's absorption indicates that taking it with food can slow the rate at which it enters the bloodstream, but generally does not reduce the overall amount absorbed. No specific food types are consistently highlighted in official constraints as being strictly prohibited.


Q: Is Proxidol effective for every patient?

A: Clinical studies evaluate the effectiveness of Proxidol based on group averages observed in trials. Official evidence summaries indicate that research does not guarantee that every individual patient will achieve the same results or respond identically to the treatment.


Q: What happens when Proxidol reaches its full effect?

A: When Proxidol reaches its full effect, the active ingredient is modulating the body's processes to achieve its documented therapeutic actions. This results in the expected relief of symptoms, which include pain reduction, inflammation attenuation, and fever lowering.


Q: What is Proxidol generally used for, besides the main conditions?

A: According to the official product information, the approved therapeutic indications for Proxidol generally include the management of mild to moderate pain, relief of inflammation caused by various forms of arthritis, and the treatment of acute pain associated with conditions like primary dysmenorrhea.


Q: What should I do if I miss a dose of Proxidol?

A: Official regulatory guidance for missed doses states that taking it as soon as it is remembered is generally advised. However, if it is already close to the time for the next scheduled dose, the regulatory instruction is to skip the missed dose entirely and resume the normal schedule.


Q: Is it true that Proxidol can cause changes in appetite?

A: Official adverse reaction reports list a range of gastrointestinal effects that have been observed in some patients. These documented side effects include changes in both appetite and thirst.


Q: Why do some people experience trouble sleeping after starting Proxidol?

A: The official product information lists insomnia (difficulty sleeping) and nervousness among the reported side effects affecting the central nervous system. These are potential adverse reactions that some patients may experience while taking the medicine.


Q: Is the tiredness caused by Proxidol permanent?

A: Side effects such as drowsiness or fatigue are noted in official safety documents as generally temporary adverse reactions. There is no documented evidence in official regulatory sources indicating that these effects become permanent.


Q: Can Proxidol cause weight gain or loss?

A: Fluid retention, officially termed edema, is a documented adverse reaction in safety documents. As fluid retention can be linked to changes in the body's fluid balance, it may result in changes in body weight.


Q: What happens if I stop taking Proxidol suddenly?

A: As a Nonsteroidal Anti-inflammatory Drug (NSAID), Proxidol is not associated with a formal discontinuation or withdrawal syndrome. Stopping the medicine suddenly will most often result only in the return of the underlying symptoms (like pain or inflammation) it was being used to address.


Q: How long does Proxidol stay in the body?

A: The speed at which the medicine is cleared from the body is tracked by its plasma half-life. For Proxidol, the half-life is documented in pharmacokinetic data to be approximately 12 to 17 hours, which is the time required for half the amount of the active ingredient to be eliminated.


Q: Is Proxidol considered a controlled substance?

A: Proxidol (Naproxen Sodium) is officially reviewed by regulatory agencies responsible for drug scheduling. It is classified in government databases as not being a controlled substance.


Q: Does Proxidol interact with birth control pills?

A: Regulatory documents covering drug interactions state that there is no known clinically significant interaction between Proxidol and oral contraceptive medications (birth control pills).


Q: Can Proxidol affect lab test results?

A: Official prescribing information notes that the active ingredient may interfere with certain diagnostic laboratory tests. Specifically, it can affect results for tests involving urinary 5-hydroxyindoleacetic acid (5-HIAA).


Q: Can I take Proxidol with other prescription pain medication?

A: Regulatory documents establish a prohibition on the co-administration of Proxidol with other prescription pain medications that contain other Nonsteroidal Anti-inflammatory Drugs (NSAIDs). This restriction is enforced due to the substantial, documented risk of severe adverse events.


Q: Is Proxidol used to treat anxiety?

A: Proxidol is officially indicated for the relief of pain, inflammation, and fever, as defined in its approved therapeutic uses. It is not listed for the treatment of anxiety disorders or other psychological conditions in official regulatory documents.

How should Proxidol be stored and disposed of?

How to Store and Dispose of Proxidol (Naproxen Sodium)

Official regulatory documents define strict storage and disposal requirements to maintain product stability and ensure public safety.

Storage Requirements

Proxidol must be stored at Controlled Room Temperature, specifically between 20 C to 25 C (68 F to 77 F), and must avoid excessive heat above 40 C. The product must be stored in the original container, which should be kept tightly closed, and must be protected from light and moisture. Consistent with regulatory mandates, the medicine must be stored out of the sight and reach of children.

Disposal Instructions

Unused or expired Proxidol should primarily be disposed of through an official drug take-back program. If this option is unavailable, the product should not be flushed down the toilet. Instead, it must be removed from its packaging, mixed with an unappealing substance, placed in a sealed container, and then discarded in the household trash, as specified by disposal guidelines.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Proxidol found in:

A-Z Index: